Michel M. Sun

1.9k total citations
12 papers, 491 citations indexed

About

Michel M. Sun is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michel M. Sun has authored 12 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michel M. Sun's work include Retinal Diseases and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Melanoma and MAPK Pathways (3 papers). Michel M. Sun is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Melanoma and MAPK Pathways (3 papers). Michel M. Sun collaborates with scholars based in United States and Israel. Michel M. Sun's co-authors include Lynn K. Gordon, Leslie A. Fogel, Anthony R. French, Leonidas N. Carayannopoulos, Michael E. Mitchell, Desiree Hollemon, Jill Garrison, Andrew B. Sparks, Kevin Lee and Patrick Pattee and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Ophthalmology.

In The Last Decade

Michel M. Sun

12 papers receiving 469 citations

Peers

Michel M. Sun
Mrinali P. Gupta United States
Chiara Ginanneschi Italy
Seiryu Kamoi Japan
Saeed Reza Ghaffari Iran
Howard A. Britton United States
Brett V. Johnson Australia
Juergen Foell Germany
Luciano Dalla Pozza Australia
Heidrun Boztug Austria
J. Maguire United States
Mrinali P. Gupta United States
Michel M. Sun
Citations per year, relative to Michel M. Sun Michel M. Sun (= 1×) peers Mrinali P. Gupta

Countries citing papers authored by Michel M. Sun

Since Specialization
Citations

This map shows the geographic impact of Michel M. Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel M. Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel M. Sun more than expected).

Fields of papers citing papers by Michel M. Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel M. Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel M. Sun. The network helps show where Michel M. Sun may publish in the future.

Co-authorship network of co-authors of Michel M. Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Michel M. Sun. A scholar is included among the top collaborators of Michel M. Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel M. Sun. Michel M. Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Meng‐Chin, David Casero, Michel M. Sun, et al.. (2024). Epithelial Membrane Protein 2 (EMP2) Blockade Attenuates Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Investigative Ophthalmology & Visual Science. 65(8). 10–10. 2 indexed citations
2.
Sun, Michel M., Ann M. Chan, Alison Chu, et al.. (2022). Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines. Scientific Reports. 12(1). 19432–19432. 6 indexed citations
3.
Braun, David, Darios Getahun, Vicki Y. Chiu, et al.. (2021). Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment. American Journal of Ophthalmology. 224. 282–291. 17 indexed citations
4.
Au, Adrian, Frederic Gunnemann, Assaf Hilely, et al.. (2020). Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis. Canadian Journal of Ophthalmology. 55(2). 116–125. 62 indexed citations
5.
Sun, Michel M., Scott P. Kelly, Gary N. Holland, et al.. (2020). Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 128(6). 910–919. 35 indexed citations
6.
Patel, Kunal, Michel M. Sun, Courtney Duong, et al.. (2020). Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. Journal of Neuro-Oncology. 147(1). 15–24. 6 indexed citations
7.
Chang, Chih‐Chiang, Alison Chu, Scott A. Meyer, et al.. (2020). Three-dimensional Imaging Coupled with Topological Quantification Uncovers Retinal Vascular Plexuses Undergoing Obliteration. Theranostics. 11(3). 1162–1175. 7 indexed citations
8.
Sun, Michel M., Madhuri Wadehra, David Casero, et al.. (2020). Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Investigative Ophthalmology & Visual Science. 61(2). 3–3. 19 indexed citations
9.
Sun, Michel M., et al.. (2019). Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model. Investigative Ophthalmology & Visual Science. 60(1). 245–245. 14 indexed citations
10.
Sun, Michel M., Ralph D. Levinson, Stephen D. Anesi, et al.. (2019). Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition. Ocular Immunology and Inflammation. 28(2). 217–227. 59 indexed citations
11.
Fogel, Leslie A., et al.. (2013). Markers of Nonselective and Specific NK Cell Activation. The Journal of Immunology. 190(12). 6269–6276. 56 indexed citations
12.
Sparks, Andrew B., Eric T. Wang, Craig A. Struble, et al.. (2012). Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis. 32(1). 3–9. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mrinali P. Gupta Breakdown of academic impact, for papers by Chiara Ginanneschi Breakdown of academic impact, for papers by Seiryu Kamoi Breakdown of academic impact, for papers by Saeed Reza Ghaffari Breakdown of academic impact, for papers by Howard A. Britton Breakdown of academic impact, for papers by Brett V. Johnson Breakdown of academic impact, for papers by Juergen Foell Breakdown of academic impact, for papers by Luciano Dalla Pozza Breakdown of academic impact, for papers by Heidrun Boztug Breakdown of academic impact, for papers by J. Maguire
Rankless by CCL
2026